State Street’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-4,341,539
| Closed | -$495K | – | 3775 |
|
|
2018
Q4 | $495K | Sell |
4,341,539
-7,108,666
| -62% | -$4.66M | ﹤0.01% | 3445 |
|
|
2018
Q3 | $19.5M | Sell |
11,450,205
-1,248,637
| -10% | -$2.23M | ﹤0.01% | 2197 |
|
|
2018
Q2 | $22.1M | Sell |
12,698,842
-7,197,018
| -36% | -$12.4M | ﹤0.01% | 2075 |
|
|
2018
Q1 | $36.4M | Sell |
19,895,860
-558,786
| -3% | -$1.18M | ﹤0.01% | 1630 |
|
|
2017
Q4 | $45.6M | Buy |
20,454,646
+7,276,438
| +55% | +$18.1M | ﹤0.01% | 1482 |
|
|
2017
Q3 | $38.2M | Buy |
13,178,208
+245,104
| +2% | +$836K | ﹤0.01% | 1556 |
|
|
2017
Q2 | $57.6M | Buy |
12,933,104
+306,989
| +2% | +$1.27M | 0.01% | 1278 |
|
|
2017
Q1 | $58.8M | Buy |
12,626,115
+6,342,446
| +101% | +$36.8M | 0.01% | 1228 |
|
|
2016
Q4 | $38.3M | Buy |
6,283,669
+653,353
| +12% | +$3.42M | ﹤0.01% | 1432 |
|
|
2016
Q3 | $31M | Buy |
5,630,316
+448,308
| +9% | +$2.1M | ﹤0.01% | 1485 |
|
|
2016
Q2 | $19.7M | Buy |
5,182,008
+1,515,232
| +41% | +$5.14M | ﹤0.01% | 1767 |
|
|
2016
Q1 | $10.1M | Sell |
3,666,776
-149,076
| -4% | -$540K | ﹤0.01% | 2166 |
|
|
2015
Q4 | $21.6M | Sell |
3,815,852
-1,289,219
| -25% | -$7.86M | ﹤0.01% | 1654 |
|
|
2015
Q3 | $27.1M | Buy |
5,105,071
+3,337,407
| +189% | +$25.8M | ﹤0.01% | 1542 |
|
|
2015
Q2 | $14.7M | Buy |
1,767,664
+32,162
| +2% | +$156K | ﹤0.01% | 2039 |
|
|
2015
Q1 | $8.02M | Buy |
1,735,502
+16,816
| +1% | +$54.7K | ﹤0.01% | 2327 |
|
|
2014
Q4 | $5.24M | Sell |
1,718,686
-2,237,282
| -57% | -$6.62M | ﹤0.01% | 2543 |
|
|
2014
Q3 | $11M | Sell |
3,955,968
-1,007,118
| -20% | -$3.65M | ﹤0.01% | 2128 |
|
|
2014
Q2 | $20.2M | Buy |
4,963,086
+1,575,400
| +47% | +$6.69M | ﹤0.01% | 1806 |
|
|
2014
Q1 | $18M | Buy |
3,387,686
+2,036,687
| +151% | +$11.4M | ﹤0.01% | 1865 |
|
|
2013
Q4 | $7.5M | Buy |
1,350,999
+96,749
| +8% | +$417K | ﹤0.01% | 2342 |
|
|
2013
Q3 | $5.65M | Buy |
1,254,250
+293,388
| +31% | +$1.32M | ﹤0.01% | 2463 |
|
|
2013
Q2 | $4.1M | Buy |
+960,862
| New | +$4.83M | ﹤0.01% | 2581 |
|
Other funds holding SGYP
State Street's SGYP Position: Q1 2019 in Review
State Street sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 4,341,539 shares — an estimated $495K sold.
State Street first reported a position in SGYP in Q2 2013 and held it in 23 quarters. The position peaked at $58.8M in Q1 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.
- State Street reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
- State Street sold 4,341,539 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $495K.
- State Street first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 23 quarters.
- State Street's Synergy Pharmaceuticals, Inc Common Stock position peaked at $58.8M in Q1 2017.
- 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.
Based on State Street's 13F filing for Q1 2019, filed 15 May 2019.